Yao-Chun Hsu

33PUBLICATIONS
113CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Gene and molecular therapyHaematologyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jul 10, 2026
Comparative Effectiveness and Safety of Atezolizumab-Bevacizumab and Durvalumab-Tremelimumab as First-Line Systemic Therapy for Hepatocellular Carcinoma: A Real-World Study.

|Jun 22, 2026
Letter: Dynamic HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation-Considerations in Interpreting Predictive Performance. Authors' Reply.

|Jun 14, 2026
Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.

|May 15, 2026
Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Toward Functional Cure or a Marginal Margin?

|Apr 29, 2026
Editorial: Using HBcrAg and HBsAg Kinetics to Optimise Monitoring After Nucleo(s)tide Analogue Withdrawal. Authors' Reply.

|Apr 07, 2026
Dynamics of Circulatory HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation Using iTACT Assays to Predict Clinical Flares and HBsAg Loss.

Ying-Nan Tsai, Jia-Ling Wu, Cheng-Hao Tseng

Pageof 6

Frequent Collaborators

11 joint publications

Mindie Nguyen

10 joint publications

Cheng-Hao Tseng

6 joint publications

Yasuhito Tanaka

4 joint publications

Ming-Lung Yu